Canaan IX L.P., Director, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 222,996 shares at $10.03 ($2.2M) on 2016-06-07, disclosed to the SEC on 2016-06-08.
Open-market sale of $2.2M CTMX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.01 | 101,767 | $1.0M | 45.6% |
| 2 | $10.01 | 101,767 | $1.0M | 45.6% |
| 3 | $10.03 | 9,731 | $98K | 4.4% |
| 4 | $10.03 | 9,731 | $98K | 4.4% |
| Total | $10.01 avg | 222,996 | $2.2M | 100% |
| Filing → |
| CTMX | SELL | 2016-11-21 | $526K | — | Filing → |
| CTMX | SELL | 2016-11-16 | $593K | — | Filing → |
| CTMX | SELL | 2016-11-14 | $1.9M | — | Filing → |